Company Filing History:
Years Active: 2003-2006
Title: Innovations of Lee K Hoong in VCAM-1 Mediated Disorders
Introduction
Lee K Hoong is an accomplished inventor based in Suwanee, GA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target VCAM-1 mediated disorders. With a total of four patents to his name, his work has the potential to impact various inflammatory and autoimmune diseases.
Latest Patents
Among his latest patents, Lee K Hoong has developed 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders. These compounds have been discovered to inhibit the expression of VCAM-1, making them useful in treating a range of disorders such as arthritis, asthma, and multiple sclerosis. Another notable patent involves thioketals and thioethers that also inhibit VCAM-1 expression, which can be applied in treating cardiovascular diseases, neurological disorders, and even cancer.
Career Highlights
Lee K Hoong is currently associated with Atherogenics, Inc., where he continues to innovate in the field of therapeutic compounds. His research focuses on developing treatments that can alleviate the symptoms of various inflammatory disorders and improve patient outcomes.
Collaborations
Lee has collaborated with notable colleagues, including Charles Q Meng and Liming Ni, who contribute to his research efforts and advancements in the field.
Conclusion
Lee K Hoong's innovative work in developing compounds for treating VCAM-1 mediated disorders showcases his dedication to improving healthcare through scientific research. His contributions are paving the way for new therapeutic options in the medical field.